Literature DB >> 20951755

Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells.

Christopher Paustian1, Richard Caspell, Terrence Johnson, Peter A Cohen, Suyu Shu, Shuwen Xu, Brian J Czerniecki, Gary K Koski.   

Abstract

It was originally reported that only a small fraction of total matured dendritic cells (DCs) produced interleukin (IL)-12, but it has never been determined whether different combinations of activating signals now shown to maximize secreted IL-12 do so through increasing output by the same IL-12 producers, or by recruiting additional cytokine-secreting cells. We therefore tested all combinations of bacterial lipopolysaccharide (LPS) (TLR4 ligand), R848 (TLR8 ligand), interferon (IFN)-γ, and CD40L for activating human monocyte-derived dendritic cells (DC), and determined by intracellular flow cytometry that enhanced IL-12 secretion was accomplished in large part by markedly increasing the proportion of cells producing IL-12, with the triple and quadruple combinations recruiting the most DC. This optimization requirement for multiple signals was not reflected in differential Toll-like receptor (TLR) expression by the cells. Interestingly, DCs activated with single TLR ligands plus IFN-γ were capable of responding with a second burst of IL-12 upon later CD40L stimulation, whereas DCs activated with R848 plus LPS were not, despite the trend of the latter for superior polarization of naive T cells toward IFN-γ-secreting Th1. These results have implications for the biology of IL-12-secreting DCs and choice of activation regimen for prospective use in DC-based immunotherapy.
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951755     DOI: 10.1016/j.humimm.2010.10.004

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

1.  Increased pro-inflammatory cytokine production after lipopolysaccharide stimulation in patients with X-linked agammaglobulinemia.

Authors:  María Edith González-Serrano; Iris Estrada-García; Dolores Mogica-Martínez; Alejandro González-Garay; Gabriela López-Herrera; Laura Berrón-Ruiz; Sara Elva Espinosa-Padilla; Marco Antonio Yamazaki-Nakashimada; Alexander Vargas-Hernández; Leopoldo Santos-Argumedo; Sergio Antonio Estrada-Parra; Francisco J Espinosa-Rosales
Journal:  J Clin Immunol       Date:  2012-06-05       Impact factor: 8.317

2.  Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.

Authors:  Mei Zhu; Wei Xu; Hong Su; Qiong Huang; Baolong Wang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Combination of TLR8 and TLR4 agonists reduces the degrading effects of nicotine on DC-NK mediated effector T cell generation.

Authors:  Mahyar Nouri-Shirazi; Saba Tamjidi; Erika Nourishirazi; Elisabeth Guinet
Journal:  Int Immunopharmacol       Date:  2018-05-24       Impact factor: 4.932

4.  In vitro activation of hTERT-specific T cell responses in lung cancer patients following chemotherapy.

Authors:  Benedikt Gahn; Matthias Staudinger; Katrin Woester; Dominique Wellnitz; Sebastian Boettcher; Martin Gramatzki; Michael Kneba
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

5.  Leukotriene C(4) prevents the complete maturation of murine dendritic cells and modifies interleukin-12/interleukin-23 balance.

Authors:  Carolina Alvarez; María M Amaral; Cecilia Langellotti; Mónica Vermeulen
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

6.  Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors.

Authors:  Juan Fu; Ian-James Malm; Deepak K Kadayakkara; Hy Levitsky; Drew Pardoll; Young J Kim
Journal:  Cancer Res       Date:  2014-05-08       Impact factor: 12.701

7.  Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.

Authors:  Ali Memarian; Maryam Nourizadeh; Farimah Masoumi; Mina Tabrizi; Amir Hossein Emami; Kamran Alimoghaddam; Jamshid Hadjati; Mahroo Mirahmadian; Mahmood Jeddi-Tehrani
Journal:  Tumour Biol       Date:  2012-11-18

8.  TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.

Authors:  Mahyar Nouri-Shirazi; Saba Tamjidi; Erika Nourishirazi; Elisabeth Guinet
Journal:  Immunol Lett       Date:  2017-12-01       Impact factor: 3.685

9.  Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs.

Authors:  Erik Berk; Ravikumar Muthuswamy; Pawel Kalinski
Journal:  Vaccine       Date:  2012-05-01       Impact factor: 3.641

Review 10.  Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.

Authors:  Ilse Van Brussel; Zwi N Berneman; Nathalie Cools
Journal:  Mediators Inflamm       Date:  2012-07-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.